- 1. VA
- (UMLS (HL7) C1611840) =Intellectual Product ;
=Clinic/Center;
| - 51. Vaginal Gel with Applicator
- (UMLS (HL7) C1553201) =Biomedical or Dental Material =Vaginal Gel;
|
- 2. VA
- [The first branch of the SUBCLAVIAN ARTERY with distribution to muscles of the NECK; VERTEBRAE; SPINAL CORD; CEREBELLUM; and interior of the CEREBRUM. ( MSH )] (UMLS (NCI) C0042559) =Body Part, Organ, or Organ Component ◊ [A state in the mid-atlantic United States. Its capital is Richmond. ( NCI )] (UMLS (NCI) C0042753) Geographic Area ;
| - 52. VAGINAL HEMATOMA
- (UMLS (ICD9CM) C0156389) =Injury or Poisoning
|
- 3. vacation home
- [A vacation home, to reach a person while on vacation. ( HL7V3.0 )] (UMLS (HL7) C1550702) =Spatial Concept =home address;
| - 53. Vaginal Itching
- (UMLS (NCI) C0042256) =Sign or Symptom
|
- 4. Vacation Home Number
- (UMLS (HL7) C1549670) =Intellectual Product =Telecommunication use code;
| - 54. Vaginal Mass
- (UMLS (NCI) C0221783) =Finding ;
|
- 5. Vacation Supply
- [Supply date is due to patient vacation ( HL7V3.0 )] (UMLS (HL7) C1555303) =Intellectual Product =Supply Appropriate;
| - 55. Vaginal Metastatic Adenocarcinoma
- (UMLS (NCI) C0862601) =Neoplastic Process
|
- 6. vaccination
- [Treatment with a vaccine. ( NCI )] (UMLS (NCI) C0042196) =Therapeutic or Preventive Procedure ;
| - 56. Vaginal Non-Neoplastic Disease
- (UMLS (NCI) C1336941) Vaginal Non-Neoplastic Disorder;
=Disease or Syndrome |
- 7. Vaccination against yellow fever
- [ ] (UMLS (ICD9CM) C0199823) =Therapeutic or Preventive Procedure
| - 57. VAGINAL PACKING
- (UMLS (ICD9CM) C1270937) =Therapeutic or Preventive Procedure
|
- 8. Vaccination not carried out
- [ ] (UMLS (ICD9CM) C1561700) =Finding
| - 58. VAGINAL RECONSTRUCTION
- (UMLS (ICD9CM) C0195196) =Therapeutic or Preventive Procedure
|
- 9. Vaccination record response
- (UMLS (HL7) C1548130) =Idea or Concept =Message type;
| - 59. Vaginal Stricture
- (UMLS (NCI) C0269208) =Disease or Syndrome
|
- 10. Vaccine
- [A Type of medicine that creates an immune protection without the recipient experiencing the disease. ( HL7V3.0 )] (UMLS (HL7) C1552558) =Intellectual Product ;
=MaterialEntityClassType;
| - 60. Vaginal Suppository
- (UMLS (HL7) C1136199) =Biomedical or Dental Material =SUPP;
|
- 11. vaccine delivery
- [ ] (UMLS (CSP) C1331096) =Health Care Activity
| - 61. VAGINAL SUSPENS & FIXAT
- [ ] (UMLS (ICD9CM) C1261299) Vaginal suspension and fixation =Therapeutic or Preventive Procedure
|
- 12. vaccine development
- [development of prophylactic preparation which is given to produce immunity to pathogenic organisms or neoplasms. ( CSP )] (UMLS (CSP) C0597634) =Research Activity ;
=immunologic substance development/preparation;
| - 62. Vaginal Tablet
- (UMLS (HL7) C0042264) =Biomedical or Dental Material =TAB;
|
- 13. vaccine evaluation
- [any process by which immunogenicity, immune response, toxicity, metabolism, absorption, preferred route of administration, safe dosage range, etc., for a vaccine or group of vaccines is determined through assessment in humans, animals or cells. ( CSP )] (UMLS (CSP) C1171370) vaccine screening;
vaccine testing =Research Activity ;
=evaluation/testing;
| - 63. Vaginal Vault
- (UMLS (HL7) C0549115) =Body Part, Organ, or Organ Component =Body Part;
|
- 14. vaccine evaluation center
- [ ] (UMLS (CSP) C1328964) =Manufactured Object; Health Care Related Organization
| - 64. VaginalRoute
- [Vaginal ( HL7V3.0 )] (UMLS (HL7) C0205537) =Functional Concept =RouteBySite;
=Douche, vaginal;
Insertion, vaginal;
Topical application, vaginal;
|
- 15. Vaccine Information
- (UMLS (HL7) C1546482) =Idea or Concept =What subject filter;
| - 65. VAGINISMUS
- (UMLS (ICD9CM) C0546846) =Disease or Syndrome ;
|
- 16. Vaccine Therapy
- [Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as BCG vaccine and Corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system. ( NCI )] (UMLS (NCI) C0042209) =Therapeutic or Preventive Procedure
| - 66. vaginitis
- [inflammation of the vagina characterized by pain and a purulent discharge. ( CSP )] (UMLS (CSP) C0042267) =Disease or Syndrome =vagina disorder;
=TRICHOMONAL VAGINITIS;
Vulvovaginitis;
Vaginosis, Bacterial;
Atrophic Vaginitis |
- 17. Vaccine-Draining Lymph Node Lymphocyte Therapy
- (UMLS (NCI) C0879364) =Therapeutic or Preventive Procedure ;
| - 67. Vaginitis and vulvovaginitis
- (UMLS (ICD9CM) C0042268) =Disease or Syndrome
|
- 18. Vaccine-Sensitized Draining Lymph Node Cells
- [Cells isolated from lymph nodes from patients, and activated in vitro to generate tumor-specific effector T cells. Lymph nodes in the lymphatics draining tumors often contain T cells that are immunologically sensitized but functionally deficient. Vaccine-sensitized draining lymph node cells are prepared by isolating these lymphocytes in vitro and stimulating them with cytokines to differentiate into mature effector cells. Vaccine-draining lymph node cells may also be produced by pharmacological activation of lymph node-derived lymphocytes with drugs such as ionomycin or with bacterial toxin; these activated lymphocytes may be expanded in culture with cytokines such as interleukin-2 prior to infusion into the patient. (NCI04) ( NCI )] (UMLS (NCI) C0879357) VDLN Cells =Cell ;
| - 68. Vaginitis and vulvovaginitis in diseases classified elsewhere
- [ ] (UMLS (ICD9CM) C0156337) =Disease or Syndrome ;
|
- 19. VaccineManufacturer
- [The manufacturer of a vaccine. ( HL7V3.0 )] (UMLS (HL7) C1553793) =Intellectual Product =CodeSystem;
=Alpha Therapeutic Corporation;
Aviron;
Chiron Corporation;
Greer Laboratories, Inc.;
Immuno International AG;
Immuno-U.S., Inc.;
Korea Green Cross Corporation;
Massachusetts Public Health Biologic Laboratories;
MedImmune, Inc.;
Merck & Co., Inc.;
North American Vaccine, Inc.;
New York Blood Center;
Organon Teknika Corporation;
Sclavo, Inc.;
Abbott Laboratories (includes Ross Products Division);
Adams Laboratories;
Armour [Inactive - use CEN];
More… | - 69. Vaginitis/vulvitis NOS
- (UMLS (ICPC) C0497477) (Vaginitis/vulvitis NOS; BAGINITISA/ BULBITISA,ESKL. E.S.T., EZ; Vaginit/vulvit ikke venerisk INA; Vaginitis/vulvitis NAO; TARKEMMIN MAARITTELEMATON KOHDUN TAI ULKOSYNNYTTIMIEN TULEHDUS; Vaginite/vulvite NP; Vaginitis/Vulvitis NNB; (108); nem megh. vaginitis/vulvitis; Vaginite/vulvite NSA; VAGINITT/VULVITT INA; Vaginite/vulvite NE; Vaginitis/vulvitis NE; VAGINIT/VULVIT UNS) =Disease or Syndrome =FEMALE GENITAL SYSTEM (INCLUDING BREAST); Diagnosis/Diseases Component
|
- 20. Vaccines administered (code = CVX)(parenteral, unless oral is noted)
- (UMLS (HL7) C1547693) =Pharmacologic Substance; Immunologic Factor =HL7 Vocabulary Version 2.5;
=Bacille Calmette-Guerin Live;
botulinum antitoxin;
cholera;
diphtheria antitoxin;
DTP;
[IM500] IMMUNOGLOBULINS;
flu vaccine;
measles;
mumps;
pertussis;
plague;
OPV;
RABIES VACCINE;
rubella;
smallpox;
TETANUS TOXOID;
TYPHOID VACCINE;
leprosy;
CMVIG;
HBIG;
Hep B, NOS;
MMR;
MMRV;
Chickenpox Vaccine;
VARICELLA ZOSTER IMMUNE GLOBULIN;
GLOBULIN,IMMUNE (IV);
HIV;
meningococcal;
Hep A, More… | - 70. VAGINOSCOPY
- (UMLS (ICD9CM) C1271437) =Diagnostic Procedure
|
- 21. VaccineType
- [The kind of vaccine. ( HL7V3.0 )] (UMLS (HL7) C1554000) =Intellectual Product =CodeSystem;
=Bacille Calmette-Guerin Live;
botulinum antitoxin;
cholera;
diphtheria antitoxin;
DTP;
[IM500] IMMUNOGLOBULINS;
flu vaccine;
measles;
mumps;
pertussis;
plague;
OPV;
RABIES VACCINE;
rubella;
smallpox;
TETANUS TOXOID;
TYPHOID VACCINE;
leprosy;
CMVIG;
HBIG;
Hep B, NOS;
MMR;
MMRV;
Chickenpox Vaccine;
VARICELLA ZOSTER IMMUNE GLOBULIN;
GLOBULIN,IMMUNE (IV);
HIV;
meningococcal;
Hep More… | - 71. vagotomy
- [interruption or removal of any part of the vagus nerve. ( CSP )] (UMLS (CSP) C0394374) =Therapeutic or Preventive Procedure =Neurological Surgery;
|
- 22. vaccinia immune globulin
- [vaccinia immune globulin ( HL7V3.0 )] (UMLS (HL7) C1548487) =Organic Chemical; Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType | - 72. Vajrayana (Tibetan)
- (UMLS (HL7) C1552069) =Idea or Concept =Religious Affiliation;
|
- 23. Vaccinia-MUC-1 Vaccine/Vaccinia-TRICOM Vaccine
- (UMLS (NCI) C1328073) =Therapeutic or Preventive Procedure ;
| - 73. valaciclovir
- [used in the management of herpes simplex virus and varicella zoster virus infections and the prophylaxis of human cytomegalovirus infections. ( CSP )] (UMLS (CSP) C0249458) =Organic Chemical; Pharmacologic Substance ;
=2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one;
[AM800] ANTIVIRALS;
valine;
=Valacyclovir Hydrochloride |
- 24. Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine
- [A vaccine formulation consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). Vaccination with PSA in combination with TRICOM may enhance antigen presentation, resulting in the augmentation of a cytotoxic T cell (CTL) immune response against tumor cells expressing PSA. ( NCI )] (UMLS (NCI) C1327973) Vaccinia-PSA-TRICOM Vaccine =Pharmacologic Substance; Immunologic Factor
| - 74. Valacyclovir Hydrochloride
- [The hydrochloride salt of valacyclovir. Valacyclovir is an acyclovir prodrug that, after metabolization, inhibits viral DNA replication. It is used in the management of herpes simplex and varicella zoster infections, as well as prophylactically for human cytomegalovirus infections. ( NCI )] (UMLS (NCI) C0771309) VALACYCLOVIR HYDROCHLORIDE PREPARATION;
=Organic Chemical; Pharmacologic Substance =valaciclovir;
=VALACYCLOVIR HYDROCHLORIDE 1 GM;
VALACYCLOVIR HYDROCHLORIDE 500 MG |
- 25. VaccinOvar
- (UMLS (NCI) C1328701) =Pharmacologic Substance; Immunologic Factor ;
| - 75. Valencian
- (UMLS (HL7) C1553365) =Population Group =Spaniard;
|
- 26. Vacuolar
- [Any membrane-enclosed spaces or cavities within a cell. ( NCI )] (UMLS (NCI) C0042219) =Cell Component
| - 76. VALERIAN
- [An extract isolated from the root of the plant Valeriana officinalis. Valeriana officinalis extract inhibits the metabolic enzyme gamma-aminobutyric acid (GABA) transaminase and stimulates the synaptic release of GABA, an inhibitory neurotransmitter, resulting in sedation. (NCI04) ( NCI )] (UMLS (NCI) C0795675) Valeriana Officinalis Extract;
=Pharmacologic Substance |
- 27. VACUUM EXT DEL W EPISIOT
- [ ] (UMLS (ICD9CM) C0177270) =Therapeutic or Preventive Procedure
| - 77. Valganciclovir
- [An antiviral agent that is being studied as a treatment for AIDS-related cytomegalovirus. It is changed in the body to ganciclovir. ( NCI )] (UMLS (NCI) C0909381) VALGANCICLOVIR PREPARATION =Organic Chemical; Pharmacologic Substance ;
=[AM800] ANTIVIRALS;
Unclassified Ingredients =VALGANCICLOVIR HCL;
|
- 28. Vacuum extraction
- [Removal of the fetus from the uterus or vagina at or near the end of pregnancy with a metal traction cup that is attached to the fetus' head. Negative pressure is applied and traction is made on a chain passed through the suction tube. (From Stedman, 26th ed & Dorland, 28th ed) ( MSH )] (UMLS (ICD9CM) C0042225) =Therapeutic or Preventive Procedure
| - 78. Valgus deformities of feet, congenital
- [ ] (UMLS (ICD9CM) C0158726) =Congenital Abnormality
|
- 29. VAD (ventricular assist device)
- [ ] (UMLS (CSP) C1456081) =Medical Device
| - 79. Valgus deformity of wrist (acquired)
- [ ] (UMLS (ICD9CM) C0158467) =Acquired Abnormality ;
|
- 30. VAG RECONST W GRFT/PROS
- [ ] (UMLS (ICD9CM) C1955500) Vaginal reconstruction with graft or prosthesis;
=Therapeutic or Preventive Procedure | - 80. valine
- [branched chain essential aminoacid. ( CSP )] (UMLS (CSP) C0042285) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance =Amino Acids, Branched-Chain;
Amino Acids, Essential;
primary aminoacid;
Unclassified Ingredient Preparations =L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-;
valaciclovir;
VALINE 600 MG;
VALINE 1.24 GM/100ML;
VALINE 0.56 GM;
VALINE 0.88 GM;
VALINE 1.75 MG/ML;
VALINE 161 MG;
VALINE 2.12 MG/ML;
VALINE 2.5 MG/ML;
VALINE 200 MG;
VALINE 2000 MG;
VALINE 252 MG;
VALINE 252 MG/100ML;
VALINE 280 MG/100ML;
VALINE 3.5 MG/ML;
VALINE 34 MG;
VALINE 390 MG;
VALINE 390 MG/100ML;
VALINE 4.25 MG/ML;
VALINE 400 MG/100ML;
VALINE 452 MG/100ML;
VALINE 5 MG/ML;
VALINE 5.6 MG;
VALINE 5.6 MG/ML;
VALINE 500 MG/100ML;
VALINE 528 MG/100ML;
VALINE 560 MG;
VALINE 560 MG/100ML;
VALINE 580 MG;
VALINE 580 MG/100ML;
VALINE 6.73 MG/ML;
VALINE 6.8 MG/ML;
VALINE 60 MG/GM;
VALINE 640 MG;
VALINE 660 MG/100ML;
VALINE 680 MG;
VALINE 680 MG/100ML;
VALINE 7.3 MG/ML;
VALINE 7.89 MG/ML;
VALINE 750 MG/100ML;
VALINE 789 MG/100ML;
VALINE 800 MG/100ML;
VALINE 820 MG;
VALINE 840 MG/100ML;
VALINE 9.6 MG/ML;
|
- 31. VAG REPAIR INVERS UTERUS
- [ ] (UMLS (ICD9CM) C0177210) =Therapeutic or Preventive Procedure
| - 81. Valium
- (UMLS (NCI) C0699187) =Organic Chemical; Pharmacologic Substance ;
|
- 32. VAG SUSP/FIX W GRFT/PROS
- [ ] (UMLS (ICD9CM) C1955501) Vaginal suspension and fixation with graft or prosthesis;
=Therapeutic or Preventive Procedure | - 82. Vallecula
- (UMLS (NCI) C0456303) =Body Part, Organ, or Organ Component
|
- 33. vagina disorder
- [deviation from or interruption of the normal structure or function of the vagina. ( CSP )] (UMLS (CSP) C0042251) =Disease or Syndrome =FEMALE GENITAL DIS NOS;
Female Reproductive System Disease =Neoplasm of the Vagina;
vaginitis;
Hematocolpos;
Vaginal Fistula;
Neoplasm of the Vagina;
vaginitis;
Discharge, vaginal;
CANDIDAL VULVOVAGINITIS;
Dyspareunia;
| - 83. Valsalva's maneuver
- [Forced expiratory effort against a closed GLOTTIS. ( MSH )] (UMLS (CSP) C0042293) =Diagnostic Procedure
|
- 34. Vagina hemorrhage
- (UMLS (NCI) C0151706) =Finding =HEMORRHAGIC COND NOS;
Pregnancy Complication;
Discharge, vaginal;
| - 84. Value
- [For an attribute (e.g., Observation.value) that represents a value whose data type is determined dynamically and is not predefined by the static class diagram. ( HL7V3.0 )] (UMLS (HL7) C1554112) =Idea or Concept =MDFAttributeType;
|
- 35. Vagina Verrucous Carcinoma
- (UMLS (NCI) C1336944) Vagina Verrucous Squamous Cell Carcinoma;
Vaginal Verrucous Carcinoma;
Vaginal Verrucous Squamous Cell Carcinoma;
Verrucous Carcinoma of the Vagina;
Verrucous Carcinoma of Vagina;
Verrucous Squamous Cell Carcinoma of the Vagina;
Verrucous Squamous Cell Carcinoma of Vagina;
=Neoplastic Process | - 85. Value code
- (UMLS (HL7) C1550427) =Intellectual Product =HL7 Vocabulary Version 2.5;
|
- 36. Vaginal Abscess
- (UMLS (NCI) C0750053) =Disease or Syndrome
| - 86. Value not found in code system
- [An attribute value was compared against the corresponding code system, and no match was found. ( HL7V3.0 )] (UMLS (HL7) C1696163) =Functional Concept =AcknowledgementDetailSyntaxErrorCode;
|
- 37. VAGINAL BIOPSY
- [Removal of tissue from the vagina for microscopic examination. ( NCI )] (UMLS (ICD9CM) C0195133) =Diagnostic Procedure
| - 87. Value range
- (UMLS (HL7) C1547411) =Idea or Concept =Data type;
|
- 38. VAGINAL CONST W GRF/PROS
- [ ] (UMLS (ICD9CM) C1955499) Vaginal construction with graft or prosthesis;
=Therapeutic or Preventive Procedure | - 88. Value type
- (UMLS (HL7) C1550401) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Address;
Extended Composite ID With Check Digit;
Name;
Reference Pointer;
Structured Numeric;
Extended Address;
Extended Person Name;
Extended Telecommunications Number;
Coded Entry;
Coded Element With Formatted Values;
Composite ID With Check Digit;
Composite ID And Name;
Composite Price;
Date;
Encapsulated Data;
Formatted Text (Display);
Money;
Numeric;
String Data.;
Time;
Telephone Number;
Time Stamp (Date & Time);
Text Data (Display);
Extended Composite Name And Number For Persons;
Extended Composite Name And Number For Organizations;
|
- 39. VAGINAL CONSTRUCTION
- (UMLS (ICD9CM) C1377996) =Therapeutic or Preventive Procedure
| - 89. Valve
- (UMLS (HL7) C1186983) =Body Part, Organ, or Organ Component ;
=Body Part;
|
- 40. Vaginal construction and reconstruction
- [ ] (UMLS (ICD9CM) C0177232) =Therapeutic or Preventive Procedure
| - 90. Valve of Vieussens
- (UMLS (NCI) C0152284) =Body Part, Organ, or Organ Component
|
- 41. Vaginal Cream
- (UMLS (HL7) C0042238) =Biomedical or Dental Material =CREAM;
=Vaginal Cream with Applicator;
| - 91. VAMP
- [A regimen containing vincristine, doxorubicin, methotrexate and prednisone used in combination with radiation therapy for the treatment of low-risk, childhood Hodgkin's lymphoma. ( NCI )] (UMLS (NCI) C0635146) =Therapeutic or Preventive Procedure ;
|
- 42. Vaginal Cuff
- (UMLS (HL7) C1550321) =Body Part, Organ, or Organ Component =Body Part;
| - 92. van der Hoeve Halbertsona Waardenburg syndrome
- [rare, autosomal dominant disease with variable penetrance and several known clinical subtypes; characteristics may include depigmentation of the hair and skin, congenital deafness, heterochromia iridis, medial eyebrow hyperplasia, hypertrophy of the nasal root, and especially dystopia canthorum; the underlying cause may be defective development of the neural crest (neurocristopathy); may be closely related to piebaldism; Klein-Waardenburg Syndrome refers to a disorder that also includes upper limb abnormalities. ( CSP )] (UMLS (CSP) C0043008) =Congenital Abnormality; Disease or Syndrome ;
=Abnormalities, Multiple;
Genetic Condition;
syndrome;
|
- 43. Vaginal discharge
- [A common gynecologic disorder characterized by an abnormal, nonbloody discharge from the genital tract.(MSH)] (UMLS (ICPC) C0227791) (Vaginal discharge; MAGINA JARIOA (ESKL. ODOLJARIOA); Vaginalt udflad; Vaginale afscheiding; VUOTO EMATTIMESTA; Ecoulement vaginal; vaginaler Ausfluss; hafrasha mehanartik; huvely-folyas; Perdite vaginali; UTFLOD FRA SKJEDEN; Secrecao vaginal; Secrecion vaginal; FLYTNING) Vaginal discharge =Disease or Syndrome =vagina disorder; FEMALE GENITAL SYSTEM (INCLUDING BREAST); Symptoms and Complaints Component; =Leukorrhea; Vagina hemorrhage;
| - 93. van der Waals force
- [ ] (UMLS (CSP) C0598712) =Spatial Concept ;
|
- 44. VAGINAL DOUCHE
- [The washing of the VAGINA cavity or surface with a solution. Agents or drugs can be added to the irrigation solution. ( MSH )] (UMLS (ICD9CM) C0204785) =Therapeutic or Preventive Procedure
| - 94. van der Woude syndrome
- [ ] (UMLS (CSP) C0175697) =Congenital Abnormality; Disease or Syndrome
|
- 45. Vaginal Endodermal Sinus Neoplasm
- (UMLS (NCI) C1336945) Vaginal Endodermal Sinus Tumor;
Vaginal Yolk Sac Neoplasm;
Vaginal Yolk Sac Tumor;
=Neoplastic Process ;
| - 95. vanadate
- [Oxyvanadium ions in various states of oxidation. They act primarily as ion transport inhibitors due to their inhibition of Na(+)-, K(+)-, and Ca(+)-ATPase transport systems. They also have insulin-like action, positive inotropic action on cardiac ventricular muscle, and other metabolic effects. ( MSH )] (UMLS (CSP) C0042305) =Inorganic Chemical
|
- 46. VAGINAL ENTEROCELE
- [An intestinal HERNIA. ( MSH )] (UMLS (ICD9CM) C0205792) =Disease or Syndrome; Anatomical Abnormality
| - 96. Vancenase
- (UMLS (NCI) C0699072) =Steroid; Pharmacologic Substance
|
- 47. vaginal fluid
- [ ] (UMLS (CSP) C0392908) =Body Substance ;
| - 97. Vanceril
- (UMLS (NCI) C0699073) =Steroid; Pharmacologic Substance
|
- 48. Vaginal foam with applicator
- (UMLS (HL7) C1373239) =Biomedical or Dental Material =Vaginal foam;
| - 98. VANCOMYCIN
- [antibacterial obtained from Streptomyces orientalis; a glycopeptide that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. ( CSP )] (UMLS (NCI) C0042313) =Amino Acid, Peptide, or Protein; Antibiotic ;
=Antibiotics;
glycopeptide;
Glycoside;
[AM900] ANTI-INFECTIVES, OTHER =VANCOMYCIN HYDROCHLORIDE |
- 49. Vaginal Fornix
- (UMLS (NCI) C0227794) =Body Location or Region
| - 99. vanillylmandelate
- [ ] (UMLS (CSP) C0178883) =Organic Chemical; Biologically Active Substance ;
|
- 50. Vaginal Gel
- (UMLS (HL7) C0042257) =Biomedical or Dental Material =GEL;
=Vaginal Gel with Applicator;
| - 100. Vaniqa
- (UMLS (NCI) C0939525) =Organic Chemical; Pharmacologic Substance ;
|
home
